Clinical trial
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
NCT00647348 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00647348 |
|---|---|
| Title | Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis |
| Official title | A Phase II Randomised, Placebo-controlled Clinical Trial of Simvastatin in Patients With Secondary Progressive Multiple Sclerosis. |
| Acronym | MS-STAT |
| Lead sponsor | Imperial College London, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Secondary Progressive Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Simvastatin, Placebo |
| Enrollment | 140 |
| Start date | Jan 1, 2008 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Mar 31, 2008 |
| Last update posted | Dec 12, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: